首页> 外文期刊>Biologie aujourd’hui >Nanovaccines: Nanocarriers for antigen delivery
【24h】

Nanovaccines: Nanocarriers for antigen delivery

机译:纳米疫苗:用于抗原递送的纳米载体

获取原文
获取原文并翻译 | 示例
           

摘要

Vaccination has become one of the most important health interventions of our times, revolutionizing health care, and improving the quality of life and life expectancy of millions all over the world. In spite of this, vaccine research remains a vast field for innovation and improvement. Indeed, the shift towards the use of sub-unit antigens, much safer but less immunogenic, and the recognized need to facilitate the access to vaccines in the global framework is currently stimulating the search for safe and efficient adjuvants and delivery technologies. Within this context, nanocarriers have gained particular attention over the last years and appear as one of the most promising strategies for antigen delivery. A number of biomaterials and technologies can be used to design nanovaccines that fulfill the requirements of new vaccination approaches, such as single-dose and transmucosal immunization, critical for achieving a widespread coverage while reducing the overall costs in relation to traditional forms of vaccination. Here we present an overview of the current state of nanocarriers for antigen delivery, developed with the perspective of contributing to the global vaccination goal. ? 2013 Soci??t?? de Biologie.
机译:疫苗接种已成为当今时代最重要的健康干预措施之一,它彻底改变了医疗保健,并改善了全世界数百万人的生活质量和预期寿命。尽管如此,疫苗研究仍然是创新和改进的广阔领域。的确,向使用亚单位抗原的转变,安全性更高但免疫原性更低,并且公认的在全球框架内促进获得疫苗的需求正在刺激对安全有效的佐剂和递送技术的寻找。在这种情况下,纳米载体在过去几年中受到了特别的关注,并成为抗原递送的最有希望的策略之一。可以使用多种生物材料和技术来设计满足新疫苗接种方法要求的纳米疫苗,例如单剂量和透粘膜免疫,这对于实现广泛的覆盖范围,同时降低与传统疫苗接种形式相比的总体成本至关重要。在这里,我们概述了用于抗原递送的纳米载体的当前状态,并以有助于实现全球疫苗接种目标的观点进行了开发。 ? 2013 Soci ?? t ?? de Biologie。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号